Haemonetics reported $142.06M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Atrion ATRI:US 20.83M 3.46M
Baxter International BAX:US $ 1457M 107M
Becton, Dickinson and BDX:US $ 2067M 238M
Boston Scientific BSX:US $ 2222M 163M
Cantel Medical CMN:US $ 144.21M 4.46M
Cooper Companies COO:US $ 532.5M 14.1M
Fresenius FRE:GR € 2678M 120M
Fresenius Medical Care FME:GR € 1346M 87.9M
Globus Medical GMED:US $ 195.18M 23.8M
Haemonetics HAE:US $ 142.06M 5.79M
Hologic HOLX:US $ 559M 387.6M
Icu Medical ICUI:US $ 167.59M 1.23M
Intuitive Surgical ISRG:US $ 1023.3M 13.6M
Masimo MASI:US $ 258.2M 53.44M
Medtronic MDT:US $ 5524M 194M
Merit Medical Systems MMSI:US $ 135.07M 14.16M
Nuvasive NUVA:US $ 224.69M 13.03M
Resmed RMD:US $ 522.51M 31.31M
Steris STE:US $ 517.8M 53.82M
Stryker SYK:US $ 2843M 116M
Surmodics SRDX:US $ 19.71M 1.29M
Teleflex TFX:US $ 388.83M 42.6M
Terumo 4543:JP Y 101638M 11138M
Thermo Fisher Scientific TMO:US $ 4730M 734M
Us Physical Therapy USPH:US $ 30.82M 4.23M
Zimmer Biomet Holdings Inc ZBH:US $ 1.27B 107.6M